Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer

Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
BMC Medicine (Impact Factor: 7.28). 03/2011; 9:28. DOI: 10.1186/1741-7015-9-28
Source: PubMed

ABSTRACT Despite our substantial understanding of molecular mechanisms and gene mutations involved in cancer, the technical approaches for diagnosis and prognosis of cancer are limited. In routine clinical diagnosis of cancer, the procedure is very basic: nuclear morphology is used as a common assessment of the degree of malignancy, and hence acts as a prognostic and predictive indicator of the disease. Furthermore, though the atypical nuclear morphology of cancer cells is believed to be a consequence of oncogenic signaling, the molecular basis remains unclear. Another common characteristic of human cancer is aneuploidy, but the causes and its role in carcinogenesis are not well established.
We investigated the expression of the nuclear envelope proteins lamin A/C in ovarian cancer by immunohistochemistry and studied the consequence of lamin A/C suppression using siRNA in primary human ovarian surface epithelial cells in culture. We used immunofluorescence microscopy to analyze nuclear morphology, flow cytometry to analyze cellular DNA content, and fluorescence in situ hybridization to examine cell ploidy of the lamin A/C-suppressed cells.
We found that nuclear lamina proteins lamin A/C are often absent (47%) in ovarian cancer cells and tissues. Even in lamin A/C-positive ovarian cancer, the expression is heterogeneous within the population of tumor cells. In most cancer cell lines, a significant fraction of the lamin A/C-negative population was observed to intermix with the lamin A/C-positive cells. Down regulation of lamin A/C in non-cancerous primary ovarian surface epithelial cells led to morphological deformation and development of aneuploidy. The aneuploid cells became growth retarded due to a p53-dependent induction of the cell cycle inhibitor p21.
We conclude that the loss of nuclear envelope structural proteins, such as lamin A/C, may underlie two of the hallmarks of cancer--aberrations in nuclear morphology and aneuploidy.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: As an essential component of eukaryotic cells, the nuclear envelope (NE) plays a crucial role in many physiological processes. At present, a few membrane proteins from NE have been functional characterized. To determine whether the inner nuclear membrane (INM) protein Nurim is expressed in cancer cells with evidence of apoptosis, we identified three isoforms of this protein that are specific for human testicular seminoma and are generated by alternative splicing. We observed that Nurim is expressed in a broad range of cancer types and that its expression level is correlated with a higher tumor grade. Biochemical analysis showed that Nurim b, like a, is tightly bound to the nuclear envelope. Furthermore, knockdown using miR-Nurim resulted in an abnormal shape change of the nuclear envelope. Notably, Nurim knockdown obviously increased apoptosis induced by ultraviolet in HeLa cells. Together, these findings implicate that the INM protein Nurim plays an important role in the suppression of apoptosis.
    Current Molecular Medicine 10/2012; DOI:10.2174/156652412803833571 · 3.61 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Lamin A (LMNA) has been implicated in progeria, and more recently, a number of neoplastic diseases. Some cancers, such as ovarian cancer, are characterised by low LMNA expression chromosomal instability. In contrast, colonic cancer is associated with high LMNA expression. In this context, it is believed to contribute to cell motility and invasiveness. In this study, we have endeavoured to elucidate the relationships between the mRNA expressions of LMNA, and the clinicopathological parameters of human breast cancer. Methods: Specimens of breast cancer (BC) tissues (N=115) and normal tissues (N=30) underwent RNA extraction and reverse transcription. Transcript levels were determined using real-time quantitative PCR. Expression levels were analysed against clinicopathological data accrued over a 10 year follow-up period. Results: Higher levels of LMNA mRNA expression were seen in associated non-cancerous tissue (ANCT) (ANCT vs. cancerous tissue: 65 vs. 5; p=0.0006; Mann-Whitney). Furthermore, LMNA expression was found to be inversely associated with clinical stage (TNM1 vs. 3: 13 vs. 0.21; p=0.0515; Mann-Whitney U-test). Decreased LMNA mRNA expression was also associated with adverse clinical outcomes (disease-free survival vs. mortality: 11 vs. 1; p=0.0326; Mann-Whitney). Kaplan-Meier analysis suggested that higher LMNA expression had a highly significant association with better overall survival (p=0.004; Wilcoxon), and a moderately significant association with better disease-free survival (p=0.062; Wilcoxon). Conclusions: To our knowledge, our study is the first to study the associations of lamin A with human breast cancer. Potentially, our results suggest a significant role for nuclear and chromosomal stability in the pathogenesis of human breast cancer.
    BASO~ACS Annual Scientific Conference 2013, London; 11/2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: To elucidate the different roles of lamin A and lamin C in the metastasis of epithelial ovarian cancer (EOC) by examining their expression in EOC tissues and cell lines and their correlations with clinicopathological features. The expression of lamin A and lamin C was assessed in ovarian tissues from 61 EOC patients and 13 normal, 14 benign controls, respectively, using immunohistochemistry. Two pairs of EOC cell lines: HO-8910, HO-8910PM, SKOV-3 and SKOV-3ip were also examined to see the differential expression patterns of lamin A and lamin C. Lamin A expression was significantly lower in EOC tissues than that in normal and benign ovarian tissues (p<0.05), while lamin C expression was not. Lamin A expression level was closely associated with pathological grades, clinical stages, peritoneal metastasis and lymph node metastasis (all p<0.05). The progression-free survival rate of the EOC patients with low lamin A expression level was remarkably lower than that of the EOC patients with high expression level (p<0.05). Lamin A detected by PCR, Western Blot and immunocytochemistry also showed a significantly lower expression level in HO-8910PM than that in HO-8910 (p<0.05), but not for lamin C. There was no difference between SKOV-3 and SKOV-3ip cells. The results suggested that loss of lamin A but not lamin C expression in EOC was related to metastasis and poor prognosis. Lamin A may play a critical role in the metastasis of EOC. Copyright © 2014 Elsevier GmbH. All rights reserved.
    Pathology - Research and Practice 11/2014; 211(2). DOI:10.1016/j.prp.2014.11.008 · 1.56 Impact Factor